当前位置：首页 > 文献互助 > 互助详情

通过动态相互作用实现超耐候和自愈共凝胶，用于广泛的医疗保健和高度适应性的人机界面复制

用户lW5DvyumoRfA 19小时前 24 10 待确认 帖子自动结束时间: 2025-08-15 14:41:15

1. 请及时下载文件确认是否正确, 系统将在 2025-08-18 09:21:50 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1002/adfm.202507051复制

文献链接: https://doi.org/10.1002/adfm.202507051复制

其他信息:

上一篇：IL-1 Signal Inhibition in Alcohol-Related Hepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial of Canakinumab

下一篇：Selectivity through targeted protein degradation (TPD) miniperspective

互助时间线

2025-08-11 09:21:50 [上传文件]

大根队长上传了文件(pdf 9.96 MB), 求助状态变成 待确认

2025-08-10 14:41:15 [发起求助]

最新发布的求助

Ink Engineering in Blade-Coating Large-Area Perovskite Solar Cells 1分钟前
决奈达隆临床应用的中国专家建议 1小时前
Biologic Agents in the Treatment of Glomerular Diseases: Current Status and Future 1小时前
Type II Glycoengineered Anti-CD20 Antibody MIL62 or Cyclosporine in Chinese Primary Membranous Nephropathy: A Multicenter, Randomized, Open-Label Phase 1b/2 Trial 1小时前
… Ⅱ ANTI-CD20 MONOCLONAL ANTIBODY MIL62 OR CYCLOSPORINE IN CHINESE PRIMARY MEMBRANOUS NEPHROPATHY: PRELIMINARY RESULTS OF A … 1小时前
Flash floods: why are more of them devastating the world’s driest regions? 11小时前
Harnessing tyrosine kinase 2: Breakthroughs in autoimmune disease and cancer therapy 12小时前
A Novel PSMA/FAP-Specific Radiotracer 99mTc-HFaPSMA for Diagnosis of PSMA-Negative Prostate Cancer: From Preclinical Validation to Clinical Translation 12小时前
CDK2 Inhibitors: Rationally Directed Discovery of a Novel Potent Lead derived from Cyclohepta[e]thieno[2,3-b]pyridine 12小时前
Synthesis and evaluation of novel substituted N-(2-phenylbutyl)-5,6,7,8-tetrahydro-quinazolin-4-amines as allosteric modulators of HIV-DAT-tat interaction 12小时前
Determination of the decapping efficiency of THIOMAB™ antibodies with the engineered cysteine in the Fc region for making antibody–drug conjugates by specific hinge fragmentation-liquid chromatography 13小时前
IRAK4: potential therapeutic target for airway disease exacerbations 14小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com